Impact of islet transplantation on glycemic control as evidenced by a continuous glucose monitoring system

Journal of Diabetes Science and Technology

Volumn 2, Issue 2, 2008, Pages 221-228

  Gorn, Lisa ^a   Faradji, Raquel N ^a   Messinger, Shari ^a   Monroy, Kathy ^a   Baidal, David A ^a   Froud, Tatiana ^a   Mastrototaro, John ^b   Ricordi, Camillo ^a   Alejandro, Rodolfo ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b Sensors and Implantable Products R and D   (United States)

Author keywords

Continuous glucose monitoring system; Diabetes; Graft dysfunction; Islet transplantation; Islets; Metabolism

Indexed keywords

EID: 67651239780     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229680800200208     Document Type: Article

References (20)

1. The Diabetes Control and Complications Trial Research. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.. N Engl J Med. 1993;329(14):977-86.
2. Rickels MR, Schutta MH, Mueller R, Markmann JF, Barker CF, Naji A, Teff KL. Islet cell hormonal responses to hypoglycemia after human islet transplantation for type 1 diabetes.. Diabetes. 2005;54(11):3205-11.
3. Shapiro AM, Ricordi C, Hering BJ, Auchincloss H, Lindblad R, Robertson RP, Secchi A, Brendel MD, Berney T, Brennan DC, Cagliero E, Alejandro R, Ryan EA, Di Mercurio B, Morel P, Polonsky KS, Reems JA, Bretzel RG, Bertuzzi F, Froud T, Kandaswamy R, Sutherland DE, Eisenbarth G, Segal M, Preiksaitis J, Korbutt GS, Barton FB, Viviano L, Seyfert-Margolis V, Bluestone J, Lakey JR. International trial of the Edmonton protocol for islet transplantation. N Engl J Med. 2006;355(13):1318-30.
4. Shapiro AM, Lakey JR, Ryan EA, Korbutt GS, Toth E, Warnock GL, Kneteman NM, Rajotte RV. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen.. N Engl J Med. 2000;343(4):230-8.
5. Froud T, Ricordi C, Baidal DA, Hafz MM, Ponte G, Cure P, Pileggi A, Poggioli R, Ichii H, Khan A, Ferreira J V, Pugliese A, Esquenazi V V, Kenyon NS, Alejandro R. Islet transplantation in type 1 diabetes mellitus using cultured islets and steroidfree immunosuppression: Miami experience.. Am J Transplant. 2005;5(8):2037-46.
6. Poggioli R, Faradji RN, Ponte G, Betancourt A, Messinger S, Baidal DA, Froud T, Ricordi C, Alejandro R. Quality of life after islet transplantation. Am J Transplant. 2006;6(2):371-8.
7. CITR annual report. 2007.
8. Ryan EA, Paty BW, Senior PA, Bigam D, Alfadhli E, Kneteman NM, Lakey JR, Shapiro AM. Five-year follow-up after clinical islet transplantation. Diabetes. 2005;54(7):2060-9.
9. Faradji RN, Monroy K, Riefkohl A, Lozano L, Gorn L, Froud T, Cure P, Baidal D, Ponte G, Messinger S, Mastrototaro J, Ricordi C, Alejandro R. Continuous glucose monitoring system for early detection of graft dysfunction in allogenic islet transplant recipients.. Transplant Proc. 2006;38(10):3274-6.
10. Hay LC, Wilmshurst EG, Fulcher G. Unrecognized hypo- and hyperglycemia in well-controlled patients with type 2 diabetes mellitus: the results of continuous glucose monitoring.. Diabetes Technol Ther. 2003;5(1):19-26.
11. Guerci B, Floriot M, Böhme P, Durain D, Benichou M, Jellimann S, Drouin P. Clinical performance of CGMS in type 1 diabetic patients treated by continuous subcutaneous insulin infusion using insulin analogs.. Diabetes Care. 2003;26(3):582-9.
12. Geiger MC, Ferreira JV, Hafiz MM, Froud T, Baidal DA, Meneghini LF, Ricordi C, Alejandro R. Evaluation of metabolic control using a continuous subcutaneous glucose monitoring system in patients with type 1 diabetes mellitus who achieved insulin independence after islet cell transplantation.. Cell Transplant. 2005;14(2-3):77-84.
13. Ricordi C, Lacy PE, Finke EH, Olack BJ, Scharp DW. Automated method for isolation of human pancreatic islets. Diabetes. 1988;37(4):413-20.
14. Pileggi A, Ricordi C, Kenyon NS, Froud T, Baidal DA, Kahn A, Selvaggi G, Alejandro R. Twenty years of clinical islet transplantation at the Diabetes Research Institute-University of Miami.. Clin Transpl. 2004;177-204.
15. Mastrototaro JJ. The MiniMed continuous glucose monitoring system. Diabetes Technol Ther. 2000;2Suppl 1:S13-8.
16. Faradji RN, Monroy K, Messinger S, Pileggi A, Froud T, Baidal DA, Cure PE, Ricordi C, Luzi L, Alejandro R. Simple measures to monitor beta-cell mass and assess islet graft dysfunction. Am J Transplant. 2007;7(2):303-8.
17. Pedersen-Bjergaard U, Pramming S, Heller SR, Wallace TM, Rasmussen AK, Jørgensen HV, Matthews DR, Hougaard P, Thorsteinsson B. Severe hypoglycaemia in 1076 adult patients with type 1 diabetes: infuence of risk markers and selection.. Diabetes Metab Res Rev. 2004;20(6):479-86.
18. Ryan EA, Shandro T, Green K, Paty BW, Senior PA, Bigam D, Shapiro AM, Vantyghem MC. Assessment of the severity of hypoglycemia and glycemic lability in type 1 diabetic subjects undergoing islet transplantation.. Diabetes. 2004;53(4):955-62.
19. Kessler L, Passemard R, Oberholzer J, Benhamou PY, Bucher P, Toso C, Meyer P, Penfornis A, Badet L, Wolf P, Colin C, Morel P, Pinget M; GRAGIL Group. Reduction of blood glucose variability in type 1 diabetic patients treated by pancreatic islet transplantation: interest of continuous glucose monitoring.. Diabetes Care. 2002;25(12):2256-62.
20. Paty BW, Senior PA, Lakey JR, Shapiro AM, Ryan EA. Assessment of glycemic control after islet transplantation using the continuous glucose monitor in insulin-independent versus insulin-requiring type 1 diabetes subjects.. Diabetes Technol Ther. 2006. 8(2): p. 165-73.